Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | MLYCD | O95822 | 4/20 | 0.44 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.44 |
| ▸ | PTGES | O14684 | 2/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27470357 | 0.81 | HDAC8 (0.50) | HDAC8ALDH1A1TSHRGLAMLYCD | |
| SCHEMBL11610525 | 0.80 | ALDH1A1 (0.50) | ALDH1A1TSHRGLASMN1; SMN2HSP90AA1 | |
| SCHEMBL1241458 | 0.80 | PTGES (0.63) | NR1H4PTGESALOX5 | |
| SCHEMBL10917307 | 0.80 | ALDH1A1 (0.70) | ALDH1A1TSHRGLASMN1; SMN2MEN1 | |
| SCHEMBL1241574 | 0.77 | PTGES (0.64) | ALDH1A1GLAMLYCDNR1H4PTGES | |
| SCHEMBL1242713 | 0.77 | SERPINE1 (0.58) | NR1H4PTGESALOX5 | |
| SCHEMBL4441053 | 0.77 | NR1H4 (0.52) | ALDH1A1NR1H4PTGESALOX5 | |
| SCHEMBL11665290 | 0.76 | HDAC8 (0.64) | HDAC8ALDH1A1TSHRGLAMLYCD | |
| SCHEMBL1241489 | 0.75 | PTGES (0.58) | NR1H4PTGESALOX5 | |
| SCHEMBL1239951 | 0.74 | PTGES (0.54) | ALDH1A1NR1H4PTGESALOX5MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8383829-B2 | Electrochromic compound, electrode, and display element | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-02-26 | — | — | US | disclosed |
| US-20090256121-A1 | ELECTROCHROMIC COMPOUND, ELECTRODE, AND DISPLAY ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090256121-A1 | ELECTROCHROMIC COMPOUND, ELECTRODE, AND DISPLAY ELEMENT | SCN11A, HCN2, RER1 | HDAC8 1324/4885ALDH1A1 2559/4885TSHR 611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.